

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 8.60218612 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.38273254 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.38273254 |
| 4 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.30870825 |
| 5 | regulation of guanylate cyclase activity (GO:0031282) | 7.27605811 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.07940620 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 7.07940620 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.64713927 |
| 9 | NADH metabolic process (GO:0006734) | 6.53935911 |
| 10 | epoxygenase P450 pathway (GO:0019373) | 6.47809958 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.43752677 |
| 12 | intestinal absorption (GO:0050892) | 6.41076750 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 6.07057652 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 6.07057652 |
| 15 | tryptophan catabolic process (GO:0006569) | 6.07057652 |
| 16 | kynurenine metabolic process (GO:0070189) | 5.93831336 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.76600005 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.70300201 |
| 19 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.67955857 |
| 20 | glyoxylate metabolic process (GO:0046487) | 5.60301005 |
| 21 | urea cycle (GO:0000050) | 5.58433441 |
| 22 | urea metabolic process (GO:0019627) | 5.58433441 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.54148880 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.46568517 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 5.37969224 |
| 26 | negative regulation of fibrinolysis (GO:0051918) | 5.33146518 |
| 27 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.30970673 |
| 28 | cysteine metabolic process (GO:0006534) | 5.27951128 |
| 29 | regulation of fibrinolysis (GO:0051917) | 5.16907870 |
| 30 | protein carboxylation (GO:0018214) | 5.15699844 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.15699844 |
| 32 | regulation of protein activation cascade (GO:2000257) | 5.13484582 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 5.12617869 |
| 34 | complement activation, alternative pathway (GO:0006957) | 5.11723897 |
| 35 | bile acid metabolic process (GO:0008206) | 5.02700916 |
| 36 | fructose metabolic process (GO:0006000) | 4.99522116 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 4.98247499 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.95733018 |
| 39 | serine family amino acid catabolic process (GO:0009071) | 4.94464277 |
| 40 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.91781442 |
| 41 | endocrine process (GO:0050886) | 4.91781442 |
| 42 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.91781442 |
| 43 | lipoprotein transport (GO:0042953) | 4.89925571 |
| 44 | reverse cholesterol transport (GO:0043691) | 4.86659011 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.84131467 |
| 46 | aromatic amino acid family metabolic process (GO:0009072) | 4.82924611 |
| 47 | renal system process involved in regulation of blood volume (GO:0001977) | 4.82522533 |
| 48 | homocysteine metabolic process (GO:0050667) | 4.81456661 |
| 49 | regulation of complement activation (GO:0030449) | 4.77983689 |
| 50 | negative regulation of sterol transport (GO:0032372) | 4.76582893 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 4.76582893 |
| 52 | hormone catabolic process (GO:0042447) | 4.75726800 |
| 53 | plasma lipoprotein particle remodeling (GO:0034369) | 4.75349604 |
| 54 | protein-lipid complex remodeling (GO:0034368) | 4.75349604 |
| 55 | macromolecular complex remodeling (GO:0034367) | 4.75349604 |
| 56 | phospholipid efflux (GO:0033700) | 4.72181143 |
| 57 | drug metabolic process (GO:0017144) | 4.71977988 |
| 58 | acylglycerol homeostasis (GO:0055090) | 4.67389969 |
| 59 | triglyceride homeostasis (GO:0070328) | 4.67389969 |
| 60 | bile acid and bile salt transport (GO:0015721) | 4.63247939 |
| 61 | diacylglycerol metabolic process (GO:0046339) | 4.61350806 |
| 62 | tyrosine metabolic process (GO:0006570) | 4.60463405 |
| 63 | lysine metabolic process (GO:0006553) | 4.50939442 |
| 64 | lysine catabolic process (GO:0006554) | 4.50939442 |
| 65 | amino-acid betaine metabolic process (GO:0006577) | 4.50248066 |
| 66 | alpha-amino acid catabolic process (GO:1901606) | 4.49412811 |
| 67 | regulation of systemic arterial blood pressure (GO:0003073) | 4.47422847 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.37523143 |
| 69 | regulation of cGMP biosynthetic process (GO:0030826) | 4.37340190 |
| 70 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.34305787 |
| 71 | cholesterol efflux (GO:0033344) | 4.33127482 |
| 72 | cellular glucuronidation (GO:0052695) | 4.30667041 |
| 73 | indolalkylamine metabolic process (GO:0006586) | 4.29206170 |
| 74 | plasma lipoprotein particle clearance (GO:0034381) | 4.29077092 |
| 75 | coenzyme catabolic process (GO:0009109) | 4.27344591 |
| 76 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.27019901 |
| 77 | imidazole-containing compound metabolic process (GO:0052803) | 4.23960002 |
| 78 | drug catabolic process (GO:0042737) | 4.22636105 |
| 79 | regulation of cellular extravasation (GO:0002691) | 4.22286139 |
| 80 | glycine metabolic process (GO:0006544) | 4.21243655 |
| 81 | cellular biogenic amine catabolic process (GO:0042402) | 4.20070784 |
| 82 | amine catabolic process (GO:0009310) | 4.20070784 |
| 83 | glutamate metabolic process (GO:0006536) | 4.18646666 |
| 84 | cellular amino acid catabolic process (GO:0009063) | 4.15621530 |
| 85 | plasma lipoprotein particle assembly (GO:0034377) | 4.14989873 |
| 86 | positive regulation of pseudopodium assembly (GO:0031274) | 4.12779091 |
| 87 | positive regulation of respiratory burst (GO:0060267) | 4.09055271 |
| 88 | benzene-containing compound metabolic process (GO:0042537) | 4.08054831 |
| 89 | regulation of bile acid biosynthetic process (GO:0070857) | 4.06483653 |
| 90 | intestinal cholesterol absorption (GO:0030299) | 4.05923658 |
| 91 | antibacterial humoral response (GO:0019731) | 4.03986791 |
| 92 | serine family amino acid metabolic process (GO:0009069) | 4.03210697 |
| 93 | ethanol oxidation (GO:0006069) | 4.02820375 |
| 94 | vitamin transmembrane transport (GO:0035461) | 4.00794803 |
| 95 | cellular modified amino acid catabolic process (GO:0042219) | 4.00417125 |
| 96 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.97395280 |
| 97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.97395280 |
| 98 | antimicrobial humoral response (GO:0019730) | 3.95572446 |
| 99 | arginine metabolic process (GO:0006525) | 3.93643161 |
| 100 | regulation of cholesterol homeostasis (GO:2000188) | 3.91831231 |
| 101 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.91173265 |
| 102 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.90405784 |
| 103 | serine family amino acid biosynthetic process (GO:0009070) | 3.90232392 |
| 104 | cholesterol homeostasis (GO:0042632) | 3.87937574 |
| 105 | low-density lipoprotein particle remodeling (GO:0034374) | 3.86357725 |
| 106 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.84865418 |
| 107 | uronic acid metabolic process (GO:0006063) | 3.82514342 |
| 108 | glucuronate metabolic process (GO:0019585) | 3.82514342 |
| 109 | fibrinolysis (GO:0042730) | 3.81983853 |
| 110 | sterol homeostasis (GO:0055092) | 3.81871816 |
| 111 | aldehyde catabolic process (GO:0046185) | 3.80377532 |
| 112 | GDP-mannose metabolic process (GO:0019673) | 3.78914377 |
| 113 | phospholipid homeostasis (GO:0055091) | 3.78480861 |
| 114 | ketone body metabolic process (GO:1902224) | 3.78349377 |
| 115 | flavonoid metabolic process (GO:0009812) | 3.76540371 |
| 116 | regulation of vitamin metabolic process (GO:0030656) | 3.76169068 |
| 117 | positive regulation of lipid catabolic process (GO:0050996) | 3.75193075 |
| 118 | protein-lipid complex assembly (GO:0065005) | 3.73110931 |
| 119 | regulation of pseudopodium assembly (GO:0031272) | 3.67322257 |
| 120 | plasma lipoprotein particle organization (GO:0071827) | 3.66306812 |
| 121 | organic acid catabolic process (GO:0016054) | 3.65232923 |
| 122 | carboxylic acid catabolic process (GO:0046395) | 3.65232923 |
| 123 | virion attachment to host cell (GO:0019062) | 3.65000902 |
| 124 | adhesion of symbiont to host cell (GO:0044650) | 3.65000902 |
| 125 | peptide catabolic process (GO:0043171) | 3.64739118 |
| 126 | cofactor catabolic process (GO:0051187) | 3.64611448 |
| 127 | blood coagulation, intrinsic pathway (GO:0007597) | 3.64477183 |
| 128 | short-chain fatty acid metabolic process (GO:0046459) | 3.63726796 |
| 129 | complement activation, classical pathway (GO:0006958) | 3.63487314 |
| 130 | negative regulation of lipase activity (GO:0060192) | 3.63006022 |
| 131 | exogenous drug catabolic process (GO:0042738) | 3.62996887 |
| 132 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.60293298 |
| 133 | alkaloid metabolic process (GO:0009820) | 3.59466231 |
| 134 | acetyl-CoA metabolic process (GO:0006084) | 3.58537000 |
| 135 | protein activation cascade (GO:0072376) | 3.58240826 |
| 136 | regulation of cGMP metabolic process (GO:0030823) | 3.58146291 |
| 137 | complement activation (GO:0006956) | 3.57942228 |
| 138 | lipoprotein metabolic process (GO:0042157) | 3.57916219 |
| 139 | glycosphingolipid catabolic process (GO:0046479) | 3.56440124 |
| 140 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.53775192 |
| 141 | glycolipid catabolic process (GO:0019377) | 3.53516344 |
| 142 | peptide hormone processing (GO:0016486) | 3.52850348 |
| 143 | digestion (GO:0007586) | 3.47631968 |
| 144 | vitamin transport (GO:0051180) | 3.46891825 |
| 145 | glomerular filtration (GO:0003094) | 3.45241824 |
| 146 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.44549328 |
| 147 | sulfate transmembrane transport (GO:1902358) | 3.43990130 |
| 148 | ethanol metabolic process (GO:0006067) | 3.39901658 |
| 149 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.31398625 |
| 150 | sphingomyelin metabolic process (GO:0006684) | 3.27187999 |
| 151 | regulation of respiratory burst (GO:0060263) | 3.24544864 |
| 152 | cGMP-mediated signaling (GO:0019934) | 3.22036046 |
| 153 | drug transport (GO:0015893) | 3.21469912 |
| 154 | adhesion of symbiont to host (GO:0044406) | 3.21117440 |
| 155 | digestive system process (GO:0022600) | 3.20227116 |
| 156 | renal filtration (GO:0097205) | 3.19076502 |
| 157 | transcytosis (GO:0045056) | 3.17098230 |
| 158 | proline biosynthetic process (GO:0006561) | 3.16532426 |
| 159 | oligosaccharide biosynthetic process (GO:0009312) | 3.15291630 |
| 160 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.12760507 |
| 161 | O-glycan processing (GO:0016266) | 3.11028775 |
| 162 | proline metabolic process (GO:0006560) | 3.10438629 |
| 163 | epithelial structure maintenance (GO:0010669) | 3.09823307 |
| 164 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.01048404 |
| 165 | actin filament depolymerization (GO:0030042) | 2.99908585 |
| 166 | desmosome organization (GO:0002934) | 2.99589583 |
| 167 | regulation of cholesterol metabolic process (GO:0090181) | 2.96007486 |
| 168 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.95671851 |
| 169 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.95671851 |
| 170 | sphingolipid catabolic process (GO:0030149) | 2.95096645 |
| 171 | sulfur compound transport (GO:0072348) | 2.94731716 |
| 172 | sodium ion homeostasis (GO:0055078) | 2.92929807 |
| 173 | cellular response to nitric oxide (GO:0071732) | 2.91882124 |
| 174 | glutathione biosynthetic process (GO:0006750) | 2.91355274 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.22534777 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.14047779 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.78573234 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.43467213 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.15664877 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.90703266 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.74177352 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.98005819 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.81124389 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.23155546 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.02574832 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7139526 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.91592237 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88288317 |
| 15 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.79454448 |
| 16 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.69494849 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63487972 |
| 18 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.61376711 |
| 19 | * CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.60905587 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.60857662 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.60080411 |
| 22 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.59765847 |
| 23 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.57858324 |
| 24 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.53625843 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53131129 |
| 26 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.52806745 |
| 27 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.51830305 |
| 28 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.51341349 |
| 29 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.47905388 |
| 30 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.43081594 |
| 31 | SA1_27219007_Chip-Seq_Bcells_Human | 1.42364919 |
| 32 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.41863771 |
| 33 | P68_20966046_ChIP-Seq_HELA_Human | 1.41388162 |
| 34 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.40228065 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37830653 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36367005 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34943939 |
| 38 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.34891363 |
| 39 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.32598569 |
| 40 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.31692202 |
| 41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30667456 |
| 42 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29945879 |
| 43 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.29147320 |
| 44 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.28559731 |
| 45 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.26666138 |
| 46 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.24746073 |
| 47 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.20178459 |
| 48 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20104662 |
| 49 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.19768021 |
| 50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19694759 |
| 51 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.18785852 |
| 52 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.18690119 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16185105 |
| 54 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.15919117 |
| 55 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15863829 |
| 56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.15326670 |
| 57 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14854753 |
| 58 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14666752 |
| 59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.13279889 |
| 60 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.13165368 |
| 61 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.10174733 |
| 62 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.08307248 |
| 63 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07207726 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06824374 |
| 65 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06744845 |
| 66 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.04111562 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03320157 |
| 68 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.02051510 |
| 69 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01874852 |
| 70 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.00594160 |
| 71 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.99988301 |
| 72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99560075 |
| 73 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.98394335 |
| 74 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96456028 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95282654 |
| 76 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95238419 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92941929 |
| 78 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.87925458 |
| 79 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83549833 |
| 80 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83456692 |
| 81 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82451437 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.82351348 |
| 83 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79574943 |
| 84 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77721871 |
| 85 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.77547265 |
| 86 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.76972470 |
| 87 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.76155033 |
| 88 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.75706972 |
| 89 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74583240 |
| 90 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.74105984 |
| 91 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.73305731 |
| 92 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72824518 |
| 93 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71711347 |
| 94 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70700904 |
| 95 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70615801 |
| 96 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.68148179 |
| 97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67750422 |
| 98 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67685000 |
| 99 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66914242 |
| 100 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62894542 |
| 101 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.61590493 |
| 102 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.61590493 |
| 103 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61352782 |
| 104 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.61287524 |
| 105 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.60765895 |
| 106 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.60069704 |
| 107 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59969534 |
| 108 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.58987216 |
| 109 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.58856335 |
| 110 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.58782453 |
| 111 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.58298881 |
| 112 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.57422087 |
| 113 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.57072206 |
| 114 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.56875316 |
| 115 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.56613970 |
| 116 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.54324920 |
| 117 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.53584028 |
| 118 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.52846148 |
| 119 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52248357 |
| 120 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.52033006 |
| 121 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50110129 |
| 122 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49925827 |
| 123 | GATA2_19941826_ChIP-Seq_K562_Human | 0.49067561 |
| 124 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48937419 |
| 125 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.48698100 |
| 126 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47279401 |
| 127 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.47254727 |
| 128 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.46492494 |
| 129 | CBP_21632823_ChIP-Seq_H3396_Human | 0.44891476 |
| 130 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44748914 |
| 131 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.43922377 |
| 132 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.43704417 |
| 133 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.42106078 |
| 134 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.41874173 |
| 135 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.41390219 |
| 136 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39957631 |
| 137 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.39473527 |
| 138 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.39006493 |
| 139 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.38960894 |
| 140 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.38750716 |
| 141 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.38743693 |
| 142 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.38680981 |
| 143 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38319483 |
| 144 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.37490092 |
| 145 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.36835020 |
| 146 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.36694495 |
| 147 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.36667227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.17364039 |
| 2 | MP0005360_urolithiasis | 7.87194883 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.42870950 |
| 4 | MP0005365_abnormal_bile_salt | 6.01864609 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.10422262 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.14445982 |
| 7 | MP0003252_abnormal_bile_duct | 4.03619944 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.58764584 |
| 9 | MP0003183_abnormal_peptide_metabolism | 3.44205128 |
| 10 | MP0009840_abnormal_foam_cell | 3.34816044 |
| 11 | MP0009379_abnormal_foot_pigmentation | 3.26208471 |
| 12 | MP0001666_abnormal_nutrient_absorption | 3.04026999 |
| 13 | MP0005083_abnormal_biliary_tract | 2.91053761 |
| 14 | MP0010155_abnormal_intestine_physiology | 2.71507637 |
| 15 | MP0005332_abnormal_amino_acid | 2.69823096 |
| 16 | MP0003195_calcinosis | 2.68371019 |
| 17 | MP0004147_increased_porphyrin_level | 2.64221729 |
| 18 | MP0005409_darkened_coat_color | 2.47971173 |
| 19 | MP0001664_abnormal_digestion | 2.30323823 |
| 20 | MP0003866_abnormal_defecation | 2.27926172 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.25376619 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 2.21585205 |
| 23 | MP0000609_abnormal_liver_physiology | 2.12316587 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 2.07429108 |
| 25 | MP0000490_abnormal_crypts_of | 1.97317275 |
| 26 | MP0010352_gastrointestinal_tract_polyps | 1.87364140 |
| 27 | MP0003868_abnormal_feces_composition | 1.87251454 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.86875893 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.77789034 |
| 30 | MP0000477_abnormal_intestine_morphology | 1.72378884 |
| 31 | MP0000678_abnormal_parathyroid_gland | 1.69406944 |
| 32 | MP0001873_stomach_inflammation | 1.60296581 |
| 33 | MP0001764_abnormal_homeostasis | 1.59538499 |
| 34 | MP0009697_abnormal_copulation | 1.57998148 |
| 35 | MP0005451_abnormal_body_composition | 1.52111297 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.51143216 |
| 37 | MP0004858_abnormal_nervous_system | 1.50547585 |
| 38 | MP0001188_hyperpigmentation | 1.42553993 |
| 39 | MP0002098_abnormal_vibrissa_morphology | 1.40610509 |
| 40 | MP0001663_abnormal_digestive_system | 1.40491689 |
| 41 | MP0003879_abnormal_hair_cell | 1.33579525 |
| 42 | MP0000462_abnormal_digestive_system | 1.31891257 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.30415055 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.24369392 |
| 45 | MP0003011_delayed_dark_adaptation | 1.23665750 |
| 46 | MP0005381_digestive/alimentary_phenotyp | 1.22270813 |
| 47 | MP0003656_abnormal_erythrocyte_physiolo | 1.16326072 |
| 48 | MP0000598_abnormal_liver_morphology | 1.12169470 |
| 49 | MP0003186_abnormal_redox_activity | 1.11472032 |
| 50 | MP0005501_abnormal_skin_physiology | 1.10484750 |
| 51 | MP0002254_reproductive_system_inflammat | 1.06483703 |
| 52 | MP0000537_abnormal_urethra_morphology | 1.06081076 |
| 53 | MP0005647_abnormal_sex_gland | 1.05061043 |
| 54 | MP0000604_amyloidosis | 1.01250070 |
| 55 | MP0009764_decreased_sensitivity_to | 1.00653071 |
| 56 | MP0005636_abnormal_mineral_homeostasis | 0.99699806 |
| 57 | MP0005058_abnormal_lysosome_morphology | 0.97568558 |
| 58 | MP0000566_synostosis | 0.96719634 |
| 59 | MP0009763_increased_sensitivity_to | 0.94256421 |
| 60 | MP0005084_abnormal_gallbladder_morpholo | 0.90257565 |
| 61 | MP0009642_abnormal_blood_homeostasis | 0.87119069 |
| 62 | MP0008469_abnormal_protein_level | 0.86228932 |
| 63 | MP0010368_abnormal_lymphatic_system | 0.85154282 |
| 64 | MP0002876_abnormal_thyroid_physiology | 0.83295864 |
| 65 | MP0005408_hypopigmentation | 0.81496199 |
| 66 | MP0005376_homeostasis/metabolism_phenot | 0.77464844 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 0.75073539 |
| 68 | MP0010234_abnormal_vibrissa_follicle | 0.74207359 |
| 69 | MP0009765_abnormal_xenobiotic_induced | 0.73941299 |
| 70 | MP0002078_abnormal_glucose_homeostasis | 0.73872423 |
| 71 | MP0002822_catalepsy | 0.73131608 |
| 72 | MP0009053_abnormal_anal_canal | 0.72075212 |
| 73 | MP0005174_abnormal_tail_pigmentation | 0.71244525 |
| 74 | MP0002971_abnormal_brown_adipose | 0.70631556 |
| 75 | MP0005220_abnormal_exocrine_pancreas | 0.67587891 |
| 76 | MP0005266_abnormal_metabolism | 0.67099121 |
| 77 | MP0002166_altered_tumor_susceptibility | 0.66581134 |
| 78 | MP0003303_peritoneal_inflammation | 0.65919356 |
| 79 | MP0005334_abnormal_fat_pad | 0.65805988 |
| 80 | MP0002896_abnormal_bone_mineralization | 0.63572123 |
| 81 | MP0005448_abnormal_energy_balance | 0.63203555 |
| 82 | MP0005670_abnormal_white_adipose | 0.63006575 |
| 83 | MP0004270_analgesia | 0.62861956 |
| 84 | MP0001756_abnormal_urination | 0.62019542 |
| 85 | MP0004947_skin_inflammation | 0.60958074 |
| 86 | MP0004264_abnormal_extraembryonic_tissu | 0.60336007 |
| 87 | MP0010678_abnormal_skin_adnexa | 0.59990681 |
| 88 | MP0005535_abnormal_body_temperature | 0.59761502 |
| 89 | MP0000465_gastrointestinal_hemorrhage | 0.58735384 |
| 90 | MP0001849_ear_inflammation | 0.58585482 |
| 91 | MP0004130_abnormal_muscle_cell | 0.58386711 |
| 92 | MP0001216_abnormal_epidermal_layer | 0.58149717 |
| 93 | MP0003690_abnormal_glial_cell | 0.57197182 |
| 94 | MP0003329_amyloid_beta_deposits | 0.55516984 |
| 95 | MP0009785_altered_susceptibility_to | 0.54872946 |
| 96 | MP0002249_abnormal_larynx_morphology | 0.54722307 |
| 97 | MP0009333_abnormal_splenocyte_physiolog | 0.53703884 |
| 98 | MP0001661_extended_life_span | 0.53524011 |
| 99 | MP0005025_abnormal_response_to | 0.52904445 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 0.52723964 |
| 101 | MP0005464_abnormal_platelet_physiology | 0.51653635 |
| 102 | MP0000467_abnormal_esophagus_morphology | 0.51627761 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.51511160 |
| 104 | MP0000639_abnormal_adrenal_gland | 0.51156203 |
| 105 | MP0000377_abnormal_hair_follicle | 0.50239760 |
| 106 | MP0003718_maternal_effect | 0.48619440 |
| 107 | MP0005310_abnormal_salivary_gland | 0.48616506 |
| 108 | MP0003638_abnormal_response/metabolism_ | 0.48232128 |
| 109 | MP0005166_decreased_susceptibility_to | 0.45910850 |
| 110 | MP0005395_other_phenotype | 0.45586395 |
| 111 | MP0000470_abnormal_stomach_morphology | 0.44904790 |
| 112 | MP0000013_abnormal_adipose_tissue | 0.44492374 |
| 113 | MP0001501_abnormal_sleep_pattern | 0.44353529 |
| 114 | MP0002796_impaired_skin_barrier | 0.44299085 |
| 115 | MP0008872_abnormal_physiological_respon | 0.43867132 |
| 116 | MP0008873_increased_physiological_sensi | 0.43731756 |
| 117 | MP0008874_decreased_physiological_sensi | 0.41728693 |
| 118 | MP0003724_increased_susceptibility_to | 0.41632883 |
| 119 | MP0003953_abnormal_hormone_level | 0.41473646 |
| 120 | MP0003436_decreased_susceptibility_to | 0.39857704 |
| 121 | MP0009384_cardiac_valve_regurgitation | 0.39856445 |
| 122 | MP0002928_abnormal_bile_duct | 0.39643273 |
| 123 | MP0005248_abnormal_Harderian_gland | 0.39388045 |
| 124 | MP0004782_abnormal_surfactant_physiolog | 0.39345362 |
| 125 | MP0003075_altered_response_to | 0.38625807 |
| 126 | MP0000579_abnormal_nail_morphology | 0.35872012 |
| 127 | MP0005666_abnormal_adipose_tissue | 0.34889303 |
| 128 | MP0005167_abnormal_blood-brain_barrier | 0.33794509 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.33095099 |
| 130 | MP0006082_CNS_inflammation | 0.32926468 |
| 131 | MP0009115_abnormal_fat_cell | 0.32919050 |
| 132 | MP0004043_abnormal_pH_regulation | 0.32068041 |
| 133 | MP0002132_abnormal_respiratory_system | 0.32053449 |
| 134 | MP0000249_abnormal_blood_vessel | 0.31583463 |
| 135 | MP0002837_dystrophic_cardiac_calcinosis | 0.30868967 |
| 136 | MP0000538_abnormal_urinary_bladder | 0.30539158 |
| 137 | MP0001845_abnormal_inflammatory_respons | 0.30336947 |
| 138 | MP0009672_abnormal_birth_weight | 0.28968071 |
| 139 | MP0001881_abnormal_mammary_gland | 0.28838590 |
| 140 | MP0001765_abnormal_ion_homeostasis | 0.28604430 |
| 141 | MP0001243_abnormal_dermal_layer | 0.27565297 |
| 142 | MP0003453_abnormal_keratinocyte_physiol | 0.27335667 |
| 143 | MP0004381_abnormal_hair_follicle | 0.27142526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.31741325 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.22903204 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.12016549 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.64874888 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.55348637 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.36136796 |
| 7 | Xanthomatosis (HP:0000991) | 6.23472046 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.36161203 |
| 9 | Hyperactive renin-angiotensin system (HP:0000841) | 5.18762502 |
| 10 | Complement deficiency (HP:0004431) | 5.14399997 |
| 11 | Decreased circulating renin level (HP:0003351) | 4.83462970 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.81040581 |
| 13 | Hyperammonemia (HP:0001987) | 4.56889941 |
| 14 | Joint hemorrhage (HP:0005261) | 4.55053316 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.46920940 |
| 16 | Epidermoid cyst (HP:0200040) | 4.46001819 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.36632222 |
| 18 | Widely patent fontanelles and sutures (HP:0004492) | 4.35033456 |
| 19 | Ileus (HP:0002595) | 4.34952427 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 4.32619954 |
| 21 | Hyperglycinemia (HP:0002154) | 4.31637106 |
| 22 | Fat malabsorption (HP:0002630) | 4.28432219 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.22906085 |
| 24 | Ketosis (HP:0001946) | 4.12966857 |
| 25 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.12691223 |
| 26 | Thin bony cortex (HP:0002753) | 4.12623021 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 4.10853436 |
| 28 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.10369923 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 4.07912044 |
| 30 | Metabolic alkalosis (HP:0200114) | 4.07150432 |
| 31 | Abnormality of renin-angiotensin system (HP:0000847) | 4.05534880 |
| 32 | Hyperglycinuria (HP:0003108) | 4.04481113 |
| 33 | Abnormality of methionine metabolism (HP:0010901) | 4.01708164 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 3.95048348 |
| 35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.95048348 |
| 36 | Chronic diarrhea (HP:0002028) | 3.93634020 |
| 37 | Abnormality of vitamin B metabolism (HP:0004340) | 3.81241244 |
| 38 | Hypoglycemic coma (HP:0001325) | 3.81182298 |
| 39 | Abnormality of complement system (HP:0005339) | 3.75528358 |
| 40 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.69062880 |
| 41 | Confusion (HP:0001289) | 3.67524929 |
| 42 | Hypercholesterolemia (HP:0003124) | 3.66817132 |
| 43 | Abnormality of the intrinsic pathway (HP:0010989) | 3.63468608 |
| 44 | Abdominal distention (HP:0003270) | 3.61002243 |
| 45 | Hyperbilirubinemia (HP:0002904) | 3.35479089 |
| 46 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.32242343 |
| 47 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.28781765 |
| 48 | Wide cranial sutures (HP:0010537) | 3.26879281 |
| 49 | Flat acetabular roof (HP:0003180) | 3.21333242 |
| 50 | Spontaneous abortion (HP:0005268) | 3.15825929 |
| 51 | Steatorrhea (HP:0002570) | 3.07532679 |
| 52 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06792261 |
| 53 | Ketoacidosis (HP:0001993) | 3.01789483 |
| 54 | Delayed CNS myelination (HP:0002188) | 2.98470023 |
| 55 | Myocardial infarction (HP:0001658) | 2.95947356 |
| 56 | Abnormality of serum amino acid levels (HP:0003112) | 2.90592258 |
| 57 | Hepatocellular carcinoma (HP:0001402) | 2.88498511 |
| 58 | Hypophosphatemia (HP:0002148) | 2.86003307 |
| 59 | Nausea (HP:0002018) | 2.84586849 |
| 60 | Acanthocytosis (HP:0001927) | 2.83199150 |
| 61 | Congenital sensorineural hearing impairment (HP:0008527) | 2.82683736 |
| 62 | Metabolic acidosis (HP:0001942) | 2.82634274 |
| 63 | Hypochromic microcytic anemia (HP:0004840) | 2.80627665 |
| 64 | Pigmentary retinal degeneration (HP:0001146) | 2.79018067 |
| 65 | Hyperparathyroidism (HP:0000843) | 2.78416007 |
| 66 | Nephrolithiasis (HP:0000787) | 2.75936134 |
| 67 | Abnormality of purine metabolism (HP:0004352) | 2.75656952 |
| 68 | Proximal tubulopathy (HP:0000114) | 2.75383195 |
| 69 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.73841581 |
| 70 | Villous atrophy (HP:0011473) | 2.73841581 |
| 71 | Malnutrition (HP:0004395) | 2.73037749 |
| 72 | Skin nodule (HP:0200036) | 2.72748535 |
| 73 | Delayed epiphyseal ossification (HP:0002663) | 2.71361464 |
| 74 | Vascular calcification (HP:0004934) | 2.70892370 |
| 75 | Systemic lupus erythematosus (HP:0002725) | 2.66991830 |
| 76 | Right ventricular cardiomyopathy (HP:0011663) | 2.66877790 |
| 77 | Abnormal urine phosphate concentration (HP:0012599) | 2.63755864 |
| 78 | Dicarboxylic aciduria (HP:0003215) | 2.59762438 |
| 79 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.59762438 |
| 80 | Lethargy (HP:0001254) | 2.56568506 |
| 81 | Increased purine levels (HP:0004368) | 2.56387661 |
| 82 | Hyperuricemia (HP:0002149) | 2.56387661 |
| 83 | Pili torti (HP:0003777) | 2.54077336 |
| 84 | Megaloblastic anemia (HP:0001889) | 2.50747677 |
| 85 | Enlarged epiphyses (HP:0010580) | 2.50532941 |
| 86 | Abnormal gallbladder morphology (HP:0012437) | 2.46693589 |
| 87 | Hypoglycemic seizures (HP:0002173) | 2.46401372 |
| 88 | Hypotension (HP:0002615) | 2.44788665 |
| 89 | Gout (HP:0001997) | 2.42396468 |
| 90 | Cholelithiasis (HP:0001081) | 2.41390833 |
| 91 | Abnormality of chloride homeostasis (HP:0011422) | 2.40954200 |
| 92 | Cardiovascular calcification (HP:0011915) | 2.39686583 |
| 93 | Spastic diplegia (HP:0001264) | 2.39100223 |
| 94 | Hyperaldosteronism (HP:0000859) | 2.38243284 |
| 95 | Glomerulonephritis (HP:0000099) | 2.36751160 |
| 96 | Cholecystitis (HP:0001082) | 2.34640991 |
| 97 | Abnormal gallbladder physiology (HP:0012438) | 2.34640991 |
| 98 | Potter facies (HP:0002009) | 2.34100258 |
| 99 | Facial shape deformation (HP:0011334) | 2.34100258 |
| 100 | Irritability (HP:0000737) | 2.33707591 |
| 101 | Hyperphosphaturia (HP:0003109) | 2.32938766 |
| 102 | Mitral stenosis (HP:0001718) | 2.32003088 |
| 103 | Amyloidosis (HP:0011034) | 2.31293695 |
| 104 | Cerebral edema (HP:0002181) | 2.29173247 |
| 105 | Focal segmental glomerulosclerosis (HP:0000097) | 2.28311642 |
| 106 | Abnormality of the costochondral junction (HP:0000919) | 2.28185370 |
| 107 | Late onset (HP:0003584) | 2.27591426 |
| 108 | Esophageal varix (HP:0002040) | 2.23058785 |
| 109 | Neonatal onset (HP:0003623) | 2.22745754 |
| 110 | Renal tubular acidosis (HP:0001947) | 2.22135891 |
| 111 | Protuberant abdomen (HP:0001538) | 2.20869908 |
| 112 | Pancreatitis (HP:0001733) | 2.20790066 |
| 113 | Gingival bleeding (HP:0000225) | 2.19946453 |
| 114 | Poikilocytosis (HP:0004447) | 2.19526042 |
| 115 | Sensorimotor neuropathy (HP:0007141) | 2.17254985 |
| 116 | Hydroxyprolinuria (HP:0003080) | 2.15723681 |
| 117 | Abnormality of proline metabolism (HP:0010907) | 2.15723681 |
| 118 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14173078 |
| 119 | Abnormal hair laboratory examination (HP:0003328) | 2.13499700 |
| 120 | Nephritis (HP:0000123) | 2.12869542 |
| 121 | Hypokalemia (HP:0002900) | 2.12466797 |
| 122 | Eczematoid dermatitis (HP:0000976) | 2.12060675 |
| 123 | Abnormal tarsal ossification (HP:0008369) | 2.11238182 |
| 124 | Growth hormone excess (HP:0000845) | 2.08915697 |
| 125 | Vomiting (HP:0002013) | 2.07836918 |
| 126 | Brushfield spots (HP:0001088) | 2.07774242 |
| 127 | Hyponatremia (HP:0002902) | 2.07334331 |
| 128 | Menorrhagia (HP:0000132) | 2.06365717 |
| 129 | Hemorrhage of the eye (HP:0011885) | 2.05180218 |
| 130 | Cerebral palsy (HP:0100021) | 2.05169645 |
| 131 | Enlarged kidneys (HP:0000105) | 2.03773081 |
| 132 | Myopathic facies (HP:0002058) | 2.03110701 |
| 133 | Abnormal cartilage morphology (HP:0002763) | 2.03103262 |
| 134 | Thrombophlebitis (HP:0004418) | 2.02203414 |
| 135 | Abnormality of the gallbladder (HP:0005264) | 2.01926814 |
| 136 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.00683675 |
| 137 | Hyperphosphatemia (HP:0002905) | 1.99369397 |
| 138 | Rickets (HP:0002748) | 1.98068659 |
| 139 | Generalized aminoaciduria (HP:0002909) | 1.97894416 |
| 140 | Opisthotonus (HP:0002179) | 1.97075904 |
| 141 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.94998394 |
| 142 | Posterior subcapsular cataract (HP:0007787) | 1.94221245 |
| 143 | Alkalosis (HP:0001948) | 1.93908297 |
| 144 | Renal tubular dysfunction (HP:0000124) | 1.92544164 |
| 145 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92009701 |
| 146 | Abnormality of iron homeostasis (HP:0011031) | 1.91088204 |
| 147 | Hypophosphatemic rickets (HP:0004912) | 1.86638903 |
| 148 | Dehydration (HP:0001944) | 1.86032387 |
| 149 | Abnormality of potassium homeostasis (HP:0011042) | 1.85194631 |
| 150 | Glomerulosclerosis (HP:0000096) | 1.84600864 |
| 151 | Abnormality of vitamin metabolism (HP:0100508) | 1.83706888 |
| 152 | Gastrointestinal dysmotility (HP:0002579) | 1.82153682 |
| 153 | Glycosuria (HP:0003076) | 1.81994159 |
| 154 | Abnormality of urine glucose concentration (HP:0011016) | 1.81994159 |
| 155 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81032134 |
| 156 | Reticulocytosis (HP:0001923) | 1.80748038 |
| 157 | Elevated hepatic transaminases (HP:0002910) | 1.79436636 |
| 158 | Multiple lipomas (HP:0001012) | 1.79231198 |
| 159 | Renal cortical cysts (HP:0000803) | 1.78838106 |
| 160 | Abnormal albumin level (HP:0012116) | 1.76732836 |
| 161 | Hypoalbuminemia (HP:0003073) | 1.76732836 |
| 162 | Bone pain (HP:0002653) | 1.76384264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.36099984 |
| 2 | ACVR1B | 5.76416785 |
| 3 | FGFR4 | 4.45390853 |
| 4 | ERN1 | 4.36730775 |
| 5 | TAOK3 | 4.32825631 |
| 6 | SIK1 | 4.23339670 |
| 7 | MST1R | 2.98102735 |
| 8 | ERBB4 | 2.85898063 |
| 9 | INSRR | 2.74002921 |
| 10 | TESK2 | 2.42216413 |
| 11 | FRK | 2.26778543 |
| 12 | PKN2 | 2.05063592 |
| 13 | MAP2K4 | 2.00060037 |
| 14 | MAPK11 | 1.91291878 |
| 15 | PTK6 | 1.90169009 |
| 16 | PIK3CG | 1.66051447 |
| 17 | TYK2 | 1.65394981 |
| 18 | FLT3 | 1.61193451 |
| 19 | TRIB3 | 1.55499852 |
| 20 | LATS1 | 1.55026552 |
| 21 | STK39 | 1.53276964 |
| 22 | GRK6 | 1.51110324 |
| 23 | SMG1 | 1.47903664 |
| 24 | TESK1 | 1.45179178 |
| 25 | DAPK2 | 1.41178424 |
| 26 | MAP3K7 | 1.38669410 |
| 27 | ABL2 | 1.29108544 |
| 28 | NEK9 | 1.24779865 |
| 29 | PRKAA2 | 1.24615496 |
| 30 | MAP3K10 | 1.22121471 |
| 31 | ERBB2 | 1.20756718 |
| 32 | MAP4K1 | 1.20415445 |
| 33 | DDR2 | 1.19113725 |
| 34 | RIPK1 | 1.16231793 |
| 35 | JAK2 | 1.15554462 |
| 36 | KDR | 1.15057795 |
| 37 | FGFR2 | 1.09165879 |
| 38 | OXSR1 | 1.08553373 |
| 39 | MET | 1.07999279 |
| 40 | PRPF4B | 1.04930733 |
| 41 | TBK1 | 1.04483392 |
| 42 | MAP3K14 | 1.01418686 |
| 43 | TAOK1 | 1.00571740 |
| 44 | PDK2 | 1.00224551 |
| 45 | MAP3K12 | 0.99925416 |
| 46 | MAPK15 | 0.99896029 |
| 47 | WNK4 | 0.96840325 |
| 48 | EPHB1 | 0.92983557 |
| 49 | JAK1 | 0.90724156 |
| 50 | MAP2K6 | 0.90680918 |
| 51 | RIPK4 | 0.90662092 |
| 52 | MATK | 0.89761661 |
| 53 | MAPK4 | 0.88359021 |
| 54 | PRKCZ | 0.87873511 |
| 55 | MAPKAPK3 | 0.87295673 |
| 56 | PAK4 | 0.87006475 |
| 57 | MAP2K3 | 0.84880244 |
| 58 | CDC42BPA | 0.83799732 |
| 59 | MAP3K11 | 0.82316095 |
| 60 | STK24 | 0.81435124 |
| 61 | MAP2K2 | 0.81240008 |
| 62 | MAP3K3 | 0.79848178 |
| 63 | STK38L | 0.79453675 |
| 64 | EPHB2 | 0.78725491 |
| 65 | MUSK | 0.78134383 |
| 66 | PTK2 | 0.76741849 |
| 67 | MST4 | 0.75511184 |
| 68 | CAMK2G | 0.75222214 |
| 69 | DYRK1B | 0.74645199 |
| 70 | PINK1 | 0.74289094 |
| 71 | PRKACG | 0.73984593 |
| 72 | CDK6 | 0.73642062 |
| 73 | PRKAA1 | 0.72167642 |
| 74 | CSK | 0.70706133 |
| 75 | GRK1 | 0.69849573 |
| 76 | IRAK3 | 0.69026319 |
| 77 | NME1 | 0.66992944 |
| 78 | PIK3CA | 0.64286650 |
| 79 | MAP3K13 | 0.63468635 |
| 80 | EPHA3 | 0.63451086 |
| 81 | GSK3A | 0.62666396 |
| 82 | MAP2K1 | 0.59680611 |
| 83 | PRKG2 | 0.59111773 |
| 84 | MAPK12 | 0.58946166 |
| 85 | TIE1 | 0.57738422 |
| 86 | FER | 0.57478149 |
| 87 | PDPK1 | 0.57470527 |
| 88 | ZAP70 | 0.57413432 |
| 89 | SGK3 | 0.56278172 |
| 90 | ICK | 0.55605328 |
| 91 | PRKCI | 0.55598782 |
| 92 | RPS6KA2 | 0.55093594 |
| 93 | CAMK1D | 0.53344424 |
| 94 | PRKCQ | 0.53092238 |
| 95 | EEF2K | 0.52989112 |
| 96 | CAMK2D | 0.51072805 |
| 97 | IKBKE | 0.49989661 |
| 98 | MAP3K2 | 0.48013876 |
| 99 | FGFR3 | 0.45794507 |
| 100 | PBK | 0.45562051 |
| 101 | LMTK2 | 0.45169070 |
| 102 | SRC | 0.44082495 |
| 103 | AKT3 | 0.43147853 |
| 104 | MYLK | 0.42812064 |
| 105 | PRKD2 | 0.42229286 |
| 106 | MAPK7 | 0.41694476 |
| 107 | TGFBR2 | 0.40143859 |
| 108 | PDGFRA | 0.39652692 |
| 109 | NEK6 | 0.37716048 |
| 110 | MAP3K1 | 0.37340715 |
| 111 | IRAK1 | 0.36747581 |
| 112 | CSNK1G1 | 0.36159777 |
| 113 | IGF1R | 0.36039084 |
| 114 | EPHA4 | 0.34749797 |
| 115 | LRRK2 | 0.34127170 |
| 116 | CSF1R | 0.33645361 |
| 117 | RET | 0.33629671 |
| 118 | RPS6KB2 | 0.32441154 |
| 119 | PDK1 | 0.32186762 |
| 120 | SGK2 | 0.31979580 |
| 121 | MAPKAPK2 | 0.31743774 |
| 122 | EPHA2 | 0.31176262 |
| 123 | PRKCD | 0.30866385 |
| 124 | PRKCA | 0.30781194 |
| 125 | NUAK1 | 0.30255242 |
| 126 | BMX | 0.30027809 |
| 127 | KSR2 | 0.29973029 |
| 128 | MAP3K5 | 0.29758781 |
| 129 | RPS6KC1 | 0.29709368 |
| 130 | RPS6KL1 | 0.29709368 |
| 131 | TAOK2 | 0.29158858 |
| 132 | CDK4 | 0.28399647 |
| 133 | MTOR | 0.27676952 |
| 134 | CAMK2B | 0.26685909 |
| 135 | PKN1 | 0.26180526 |
| 136 | EGFR | 0.26002879 |
| 137 | PAK3 | 0.24276350 |
| 138 | SGK223 | 0.23659381 |
| 139 | SGK494 | 0.23659381 |
| 140 | PIM2 | 0.23031910 |
| 141 | IRAK2 | 0.22941926 |
| 142 | FYN | 0.22763728 |
| 143 | MAP3K8 | 0.21867928 |
| 144 | PRKCG | 0.21862042 |
| 145 | RPS6KA6 | 0.21738516 |
| 146 | TNIK | 0.18229682 |
| 147 | MELK | 0.17811990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.38201017 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.47402869 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40827982 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.16259092 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.99950960 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71169493 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.63727986 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.59663081 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.59461510 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47693756 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.44852651 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33859042 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.30058964 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15389625 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13992147 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.03757771 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.01792986 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93479046 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91393418 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91280248 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89113140 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.86128243 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82274819 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78161865 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.75439353 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69344921 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68292451 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66743814 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.66700883 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64415459 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.64301483 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.60714836 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58392099 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56344477 |
| 35 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.51647047 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51210821 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50814584 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39734724 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.39472352 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38962327 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36188326 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33315467 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25152957 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.24491297 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.24017643 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18795303 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.16797627 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15135884 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12229517 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09131309 |
| 51 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.06593349 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02253502 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00087254 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99871490 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99031039 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94681933 |
| 57 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.94240032 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92108311 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91984485 |
| 60 | Asthma_Homo sapiens_hsa05310 | 0.84926902 |
| 61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84690857 |
| 62 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80254040 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.78950057 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.78895207 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77967880 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75100196 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.74717635 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73729989 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73465119 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72607023 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67170017 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58294130 |
| 73 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.55807181 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52298093 |
| 75 | Allograft rejection_Homo sapiens_hsa05330 | 0.51816870 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49629334 |
| 77 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48050169 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47487792 |
| 79 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46107880 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44178436 |
| 81 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.43129245 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37411327 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33266598 |
| 84 | Tight junction_Homo sapiens_hsa04530 | 0.30977598 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.28584374 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26810463 |
| 87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26432847 |
| 88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.24303241 |
| 89 | Renin secretion_Homo sapiens_hsa04924 | 0.24136618 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.22716537 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22237990 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19502276 |
| 93 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.19137620 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.14818932 |
| 95 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.14303774 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13852449 |
| 97 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.13226098 |
| 98 | Cocaine addiction_Homo sapiens_hsa05030 | 0.09430372 |
| 99 | Leishmaniasis_Homo sapiens_hsa05140 | 0.08313630 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.08253186 |
| 101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.06647405 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.06287450 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06266944 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | 0.06104846 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.03596530 |
| 106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00641449 |
| 107 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.00312691 |
| 108 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2187064 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.2100091 |
| 110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.2052311 |
| 111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1963847 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1838144 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | -0.1823922 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1710953 |
| 115 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1581187 |
| 116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1443804 |
| 117 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1341218 |
| 118 | Hepatitis C_Homo sapiens_hsa05160 | -0.1258988 |
| 119 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1166546 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1163311 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1162004 |
| 122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1141065 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0788575 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0452282 |
| 125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0076187 |

